![](/img/cover-not-exists.png)
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
Szarek, Michael, Bittner, Vera A, Aylward, Philip, Baccara-Dinet, Marie, Bhatt, Deepak L, Diaz, Rafael, Fras, Zlatko, Goodman, Shaun G, Halvorsen, Sigrun, Harrington, Robert A, Jukema, J Wouter, MoriaJournal:
European Heart Journal
DOI:
10.1093/eurheartj/ehaa649
Date:
October, 2020
File:
PDF, 912 KB
2020